skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > cerebroside > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > cerebroside > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > organooxygen compound > sphingolipid > ceramide > cerebroside > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > cerebroside > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > organooxygen compound > carboxamide > ceramide > cerebroside > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > cerebroside > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > cerebroside > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > cerebroside > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neutral glycosphingolipid > cerebroside > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > cerebroside > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > cerebroside > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > glycosylceramide > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > glycosylceramide > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > organooxygen compound > sphingolipid > ceramide > glycosylceramide > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > glycosylceramide > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > organooxygen compound > carboxamide > ceramide > glycosylceramide > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > glycosylceramide > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > glycosylceramide > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > glycosylceramide > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > glycosylceramide > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > glycosylceramide > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine
... > organooxygen compound > sphingolipid > glycosphingolipid > glycosylceramide > galactosylceramide > beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine

اصطلاح مرجح

beta-d-galactosyl-(1<->1')-n-icosanoyl-(4e,14z)-sphingadienine  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • 0

فرمول

  • C44H83NO8

والد-عملکردی دارد

نقشی دارد

اینچی

  • InChI=1S/C44H83NO8/c1-3-5-7-9-11-13-15-17-18-19-20-22-24-26-28-30-32-34-40(48)45-37(36-52-44-43(51)42(50)41(49)39(35-46)53-44)38(47)33-31-29-27-25-23-21-16-14-12-10-8-6-4-2/h8,10,31,33,37-39,41-44,46-47,49-51H,3-7,9,11-30,32,34-36H2,1-2H3,(H,45,48)/b10-8-,33-31+/t37-,38+,39+,41-,42-,43+,44+/m0/s1

اینچی‌کی

  • JNYZDNIARSRXLF-OIBHHYQOSA-N

جرم

  • 754.133

جرم تک‌ایزوتوپی

  • 753.61187

اسمایلٓ

  • [C@H]([C@@H](/C=C/CCCCCCCC/C=C/CCC)O)(NC(CCCCCCCCCCCCCCCCCCC)=O)CO[C@@H]1O[C@@H]([C@@H]([C@@H]([C@H]1O)O)O)CO

زیرمجموعه

  • 3_STAR

مترادف دقیق

  • N-[(2S,3R,4E,14Z)-1-(beta-D-galactopyranosyloxy)-3-hydroxyoctadeca-4,14-dien-2-yl]icosanamide

مترادف مرتبط

  • beta-D-galactosyl-(1<->1')-N-eicosanoyl-(4E,14Z)-sphingadienine
  • GalCer(d18:2/20:0)
  • N-(eicosanoyl)-1-beta-galactosyl-4E,14Z-sphingadienine

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:132455

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD